These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 32521450

  • 1. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M, Xing J, Pan D, Peng X, Gao P.
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [Abstract] [Full Text] [Related]

  • 2. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY, Shi ZH, Ma W, Tao DQ, Liu S, Chen L, Zhou XL.
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [Abstract] [Full Text] [Related]

  • 3. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC, Liu BQ, Chen J, De J, Nima ZB, Dunzhu CR.
    J Ethnopharmacol; 2019 May 23; 236():316-325. PubMed ID: 30851372
    [Abstract] [Full Text] [Related]

  • 4. Sini powder ameliorates the inflammatory response in rats with stress-induced non-alcoholic fatty liver disease by inhibiting the nuclear factor kappa-B / pyrin domain-containing protein 3 pathway.
    Mu J, Cheng F, Wang Q, Wang X, Zhu W, Ma C, Yin X, Ren B, Lian Y, Du X, Zhang H, Liu S, Zhang S.
    J Tradit Chin Med; 2020 Apr 23; 40(2):253-266. PubMed ID: 32242391
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY, Shi HY, Li CP, Zhong XL, Kang M.
    World J Gastroenterol; 2015 May 21; 21(19):5877-83. PubMed ID: 26019451
    [Abstract] [Full Text] [Related]

  • 7. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM, Sun Y, Wang M, Zhang XL, Zhang SJ, Gao YS, Chen L, Wu MY, Zhou L, Zhou YM, Wang Y, Zheng FJ, Li YH.
    World J Gastroenterol; 2019 Sep 14; 25(34):5105-5119. PubMed ID: 31558860
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
    Xu YJ, Yang QH, Han L, Zhang YP, Liu YZ, Jin L, Yan HZ.
    Zhong Yao Cai; 2014 Jan 14; 37(1):80-6. PubMed ID: 25090711
    [Abstract] [Full Text] [Related]

  • 10. [Effects of soothing liver and invigorating spleen recipes on NF-kappaB signal pathway related genes and proteins in primary hepatocytes of rats with NASH].
    Yang QH, Xu YJ, Feng GF, Yang XS, Han L, Zhang YP, Wang H.
    Zhong Yao Cai; 2013 Sep 14; 36(9):1469-76. PubMed ID: 24620695
    [Abstract] [Full Text] [Related]

  • 11. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J, Du H, Shen M, Zhao Z, Ye X.
    J Immunol Res; 2020 Sep 14; 2020():3413186. PubMed ID: 32884949
    [Abstract] [Full Text] [Related]

  • 12. Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs.
    Jiang J, Yan L, Shi Z, Wang L, Shan L, Efferth T.
    Phytomedicine; 2019 Nov 14; 64():153082. PubMed ID: 31541796
    [Abstract] [Full Text] [Related]

  • 13. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y, Tang K, Deng Y, Chen R, Liang S, Xie H, He Y, Chen Y, Yang Q.
    Biomed Pharmacother; 2018 Jun 14; 102():1025-1036. PubMed ID: 29710519
    [Abstract] [Full Text] [Related]

  • 14. [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].
    Yao XR, Xia F, Tang WJ, Zhou BJ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan 20; 37(1):56-62. PubMed ID: 28109099
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
    Zhou Y, Ding YL, Zhang JL, Zhang P, Wang JQ, Li ZH.
    Biomed Pharmacother; 2018 Jan 20; 97():1397-1408. PubMed ID: 29156529
    [Abstract] [Full Text] [Related]

  • 17. Malus toringoides (Rehd.) Hughes Ameliorates Nonalcoholic Fatty Liver Disease with Diabetes via Downregulation of SREBP-1c and the NF-κB Pathway In Vivo and In Vitro.
    Xie M, Gao L, Liu Z, Yuan R, Zhuoma D, Tsering D, Wang Y, Huang S, Li B.
    J Med Food; 2022 Dec 20; 25(12):1112-1125. PubMed ID: 36445749
    [Abstract] [Full Text] [Related]

  • 18. Study on the mechanism of Shenling Baizhu powder on the pathogenesis of pregnancy complicated with non-alcoholic fatty liver, based on PI3K/AKT/mTOR signal pathway.
    Le Y, Wang Z, Zhang Q, Miao L, Wang X, Han G.
    Eur J Histochem; 2024 Sep 17; 68(3):. PubMed ID: 39287141
    [Abstract] [Full Text] [Related]

  • 19. [Effects of Chinese herbal medicine Jiangzhi Granule on expressions of liver X receptor α and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease].
    Yang LL, Wang M, Liu T, Song HY, Li DF, Zheng PY, Liu P, Ji G, Ji G.
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep 17; 9(9):998-1004. PubMed ID: 21906525
    [Abstract] [Full Text] [Related]

  • 20. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.
    Li CX, Gao JG, Wan XY, Chen Y, Xu CF, Feng ZM, Zeng H, Lin YM, Ma H, Xu P, Yu CH, Li YM.
    World J Gastroenterol; 2019 Sep 14; 25(34):5120-5133. PubMed ID: 31558861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.